Description
A novel nucleoside analogue, 4'-O-Isobutyroylpeguangxienin, is frequently utilized as an antiviral therapeutic agent. Its virucidal activity spans a wide variety of RNA viruses comprising influenza, HIV, and HCV. The drug's mode of action impedes viral RNA synthesis and restrains the virus from replicating, indicating its potential inhibition of viral proliferation.